These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28556575)

  • 1. Characterizing the impact of pressure on virus filtration processes and establishing design spaces to ensure effective parvovirus removal.
    Strauss D; Goldstein J; Hongo-Hirasaki T; Yokoyama Y; Hirotomi N; Miyabayashi T; Vacante D
    Biotechnol Prog; 2017 Sep; 33(5):1294-1302. PubMed ID: 28556575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pH, NaCl concentration, and mAb concentration of feed solution on the filterability of Planova™ 20N and Planova™ BioEX.
    Hashikawa-Muto C; Yokoyama Y; Hamamoto R; Kobayashi K; Masuda Y; Nonaka K
    Biotechnol Prog; 2024; 40(2):e3420. PubMed ID: 38146091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and implementation of Planova™ BioEX virus filters in the manufacture of a new liquid intravenous immunoglobulin in China.
    Ma S; Pang GL; Shao YJ; Hongo-Hirasaki T; Shang MX; Inouye M; Jian CY; Zhu MZ; Yang HH; Gao JF; Xi ZY; Song DW
    Biologicals; 2018 Mar; 52():37-43. PubMed ID: 29434001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the performance characteristics of the Planova-series hollow-fiber parvovirus filters using confocal and electron microscopy.
    Nazem-Bokaee H; Chen D; O'Donnell SM; Zydney AL
    Biotechnol Bioeng; 2019 Aug; 116(8):2010-2017. PubMed ID: 30982955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus filtration using small pore virus filter in downstream processing of biotherapeutic products: The effect of operating pressure.
    Liu N; Xu T
    Biologicals; 2023 Nov; 84():101718. PubMed ID: 37837714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Planova filters in manufacturing processes of biologicals improve the virus safety effectively: A review of publicly available data.
    Gröner A
    Biotechnol Prog; 2024; 40(1):e3398. PubMed ID: 37985214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to achieving modular retrovirus clearance for a parvovirus filter.
    Stuckey J; Strauss D; Venkiteshwaran A; Gao J; Luo W; Quertinmont M; O'Donnell S; Chen D
    Biotechnol Prog; 2014; 30(1):79-85. PubMed ID: 24123923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles.
    Adan-Kubo J; Tsujikawa M; Takahashi K; Hongo-Hirasaki T; Sakai K
    Biotechnol Prog; 2019 Nov; 35(6):e2875. PubMed ID: 31228338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting virus filtration to continuous processing: Effects of product and process variability on filtration performance.
    Kozaili J; Rayfield W; Gospodarek A; Brower M; Strauss D
    Biotechnol Prog; 2024; 40(2):e3407. PubMed ID: 38146086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic failure mode investigation and resolution of parvovirus retentive filters.
    LaCasse D; Lute S; Fiadeiro M; Basha J; Stork M; Brorson K; Godavarti R; Gallo C
    Biotechnol Prog; 2016 Jul; 32(4):959-70. PubMed ID: 27160325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus filter scalability: Demonstration of consistent viral clearance across laboratory and manufacturing scales.
    Buesing B; Schwartz A; Shah A; Sohka T; Hirotomi N; Strauss D
    Biologicals; 2021 Jul; 72():27-32. PubMed ID: 34226123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrity testing of Planova™ BioEX virus removal filters used in the manufacture of biological products.
    Sekine S; Komuro M; Sohka T; Sato T
    Biologicals; 2015 May; 43(3):186-94. PubMed ID: 25753822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving high mass-throughput of therapeutic proteins through parvovirus retentive filters.
    Bolton GR; Basha J; Lacasse DP
    Biotechnol Prog; 2010; 26(6):1671-7. PubMed ID: 20859931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
    Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
    Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antibody solution conditions on filter performance for virus removal filter Planova 20N.
    Hongo-Hirasaki T; Komuro M; Ide S
    Biotechnol Prog; 2010; 26(4):1080-7. PubMed ID: 20730765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step.
    Nowak T; Popp B; Roth NJ
    Biologicals; 2019 Jul; 60():85-92. PubMed ID: 31105022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varying virus-spiking conditions on a virus-removal filter Planova™ 20N in a virus validation study of antibody solutions.
    Hongo-Hirasaki T; Yamaguchi K; Yanagida K; Hayashida H; Ide S
    Biotechnol Prog; 2011; 27(1):162-9. PubMed ID: 21312364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.
    Gefroh E; Dehghani H; McClure M; Connell-Crowley L; Vedantham G
    PDA J Pharm Sci Technol; 2014; 68(3):297-311. PubMed ID: 25188350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of small-scale models to understand the impact of continuous downstream bioprocessing on integrated virus filtration.
    Lute S; Kozaili J; Johnson S; Kobayashi K; Strauss D
    Biotechnol Prog; 2020 May; 36(3):e2962. PubMed ID: 31945257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
    De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
    PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.